FDA Inspection 995169 — Tongling Jieya Biologic Technology Stock Co., Ltd.

Tongling Jieya Biologic Technology Stock Co., Ltd. — FEI 3008280114

The FDA completed an inspection of Tongling Jieya Biologic Technology Stock Co., Ltd. on December 9, 2016 in Tongling. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 9, 2016
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Tongling (China)

Citations

IDCFRDescription
240121 CFR 211.194(a)(4)Complete Test Data
360221 CFR 211.160(a)Deviations from laboratory control requirements
440621 CFR 211.194(a)(2)Suitability of testing methods verified